星昊医药：回购股份注销完成暨股份变动公告

Group 1 - The company, Xinghao Pharmaceutical, announced the repurchase of 128,920 shares, which represents 0.10% of the total share capital before the repurchase [2] - The repurchased shares have been canceled as of December 31, 2025, reducing the total number of shares from 124,961,200 to 124,832,280 [2] - After the cancellation, the company has 939,763 shares remaining in treasury stock [2]